Literature DB >> 6698494

Vitamin D metabolites in postmenopausal osteoporosis.

F Loré, R Nuti, A Vattimo, A Caniggia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6698494     DOI： 10.1055/s-2007-1014696

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN： 0018-5043            Impact factor:   2.936


× No keyword cloud information.
  3 in total

1.  Effect of a long-term treatment with 1,25-dihydroxyvitamin D3 on osteocalcin in postmenopausal osteoporosis.

Authors:  A Caniggia; R Nuti; M Galli; F Loré; V Turchetti; G A Righi
Journal:  Calcif Tissue Int       Date:  1986-06       Impact factor: 4.333

2.  Relation of sex and estrogen therapy to serum fibroblast growth factor 23, serum phosphorus, and urine phosphorus: the Heart and Soul Study.

Authors:  Joachim H Ix; Michel Chonchol; Gail A Laughlin; Michael G Shlipak; Mary A Whooley
Journal:  Am J Kidney Dis       Date:  2011-08-19       Impact factor: 8.860

Review 3.  Risk factors for osteoporosis and associated fractures.

Authors:  J L Kelsey
Journal:  Public Health Rep       Date:  1989 Sep-Oct       Impact factor: 2.792
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.